Ng OT, Laeyendecker O, Redd AD, Munshaw S, Grabowski MK, Paquet AC, Evans MC, Haddad M, Huang W, Robb ML, Reynolds SJ, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, Quinn TC.

HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.

J Infect Dis, 2014; 209: 66-73. 10.1093/infdis/jit425
Salje H, Gurley ES, Homaira N, Ram PK, Haque R, Petri W, Moss WJ, Luby SP, Breysse P, Azziz-Baumgartner E.

Impact of neighborhood biomass cooking patterns on episodic high indoor particulate matter concentrations in clean fuel homes in Dhaka, Bangladesh.

Indoor Air, 2014; 24: 213-20. 10.1111/ina.12065
Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, Moore CB, Margolick JB, Moss WJ.

Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children.

J Acquir Immune Defic Syndr, 2014; 65: 505-9. 10.1097/QAI.0000000000000074
Gurley ES, Salje H, Homaira N, Ram PK, Haque R, Petri WA Jr, Bresee J, Moss WJ, Luby SP, Breysse P, Azziz-Baumgartner E.

Indoor exposure to particulate matter and age at first acute lower respiratory infection in a low-income urban community in Bangladesh.

Am J Epidemiol, 2014; 179: 967-73. 10.1093/aje/kwu002
Rainwater-Lovett K, Nkamba H, Mubiana-Mbewe M, Moore CB, Margolick J, Moss WJ.

Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.

J Acquir Immune Defic Syndr, 2014; 67: 455-62. 10.1097/QAI.0000000000000342
Moore SM, Shannon KL, Zelaya CE, Azman AS, Lessler J.

Epidemic risk from cholera introductions into Mexico.

PLoS Curr, 2014; 6: . 10.1371/currents.outbreaks.c04478c7fbd9854ef6ba923cc81eb799
Anderson KB, Gibbons RV, Cummings DA, Nisalak A, Green S, Libraty DH, Jarman RG, Srikiatkhachorn A, Mammen MP, Darunee B, Yoon IK, Endy TP.

A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand.

J Infect Dis, 2014; 209: 360-8. 10.1093/infdis/jit436
Liu SH, Cummings DA, Zenilman JM, Gravitt PE, Brotman RM.

Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling.

Cancer Epidemiol Biomarkers Prev, 2014; 23: 200-8. 10.1158/1055-9965.EPI-13-0666
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Schwartz IB, Burke DS, Cummings DA.

Potential opportunities and perils of imperfect dengue vaccines.

Vaccine, 2014; 32: 514-20. 10.1016/j.vaccine.2013.11.020
Smith DL, Perkins TA, Reiner RC Jr, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam JR, Bisanzio D, Buckee C, Chiyaka C, Cummings DA, Garcia AJ, Gatton ML, Gething PW, Hartley DM, Johnston G, Klein EY, Michael E, Lloyd AL, et al.

Recasting the theory of mosquito-borne pathogen transmission dynamics and control.

Trans R Soc Trop Med Hyg, 2014; 108: 185-97. 10.1093/trstmh/tru026
Grabowski MK, Lessler J, Redd AD, Kagaayi J, Laeyendecker O, Ndyanabo A, Nelson MI, Cummings DA, Bwanika JB, Mueller AC, Reynolds SJ, Munshaw S, Ray SC, Lutalo T, Manucci J, Tobian AA, Chang LW, Beyrer C, Jennings JM, Nalugoda F, Serwadda D, Wawer MJ, et al.

The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models.

PLoS Med, 2014; 11: e1001610. 10.1371/journal.pmed.1001610
Althouse BM, Durbin AP, Hanley KA, Halstead SB, Weaver SC, Cummings DA.

Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.

Virology, 2014; 452-453: 237-46. 10.1016/j.virol.2014.01.015
Rudolph KE, Lessler J, Moloney RM, Kmush B, Cummings DA.

Incubation periods of mosquito-borne viral infections: a systematic review.

Am J Trop Med Hyg, 2014; 90: 882-91. 10.4269/ajtmh.13-0403
Read JM, Lessler J, Riley S, Wang S, Tan LJ, Kwok KO, Guan Y, Jiang CQ, Cummings DA.

Social mixing patterns in rural and urban areas of southern China.

Proc Biol Sci, 2014; 281: 20140268. 10.1098/rspb.2014.0268
Ferguson NM, Cummings DA.

How season and serotype determine dengue transmissibility.

Proc Natl Acad Sci U S A, 2014; 111: 9370-1. 10.1073/pnas.1407648111
Kucharski AJ, Kwok KO, Wei VW, Cowling BJ, Read JM, Lessler J, Cummings DA, Riley S.

The contribution of social behaviour to the transmission of influenza A in a human population.

PLoS Pathog, 2014; 10: e1004206. 10.1371/journal.ppat.1004206
Kwok KO, Cowling BJ, Wei VW, Wu KM, Read JM, Lessler J, Cummings DA, Peiris JS, Riley S.

Social contacts and the locations in which they occur as risk factors for influenza infection.

Proc Biol Sci, 2014; 281: 20140709. 10.1098/rspb.2014.0709
Bhoomiboonchoo P, Gibbons RV, Huang A, Yoon IK, Buddhari D, Nisalak A, Chansatiporn N, Thipayamongkolgul M, Kalanarooj S, Endy T, Rothman AL, Srikiatkhachorn A, Green S, Mammen MP, Cummings DA, Salje H.

The spatial dynamics of dengue virus in Kamphaeng Phet, Thailand.

PLoS Negl Trop Dis, 2014; 8: e3138. 10.1371/journal.pntd.0003138
Lessler J, Rodriguez-Barraquer I, Cummings DA, Garske T, Van Kerkhove M, Mills H, Truelove S, Hakeem R, Albarrak A, Ferguson NM; MERS-CoV Scenario Modeling Working Group; MERS-CoV Scenario Modeling Working Group.

Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014.

PLoS Curr, 2014; 6: . 10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369
Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J Jr, Vallari AS, Justman J, Hodder S.

Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study.

J Infect Dis, 2013; 207(2): 223-31. 10.1093/infdis/jis658
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH.

HIV incidence determination in the United States: a multiassay approach.

J Infect Dis, 2013; 207(2): 232-9. 10.1093/infdis/jis659
Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH.

Estimation of HIV incidence using multiple biomarkers.

Am J Epidemiol, 2013; 77(3): 264-72. 10.1093/aje/kws436
Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O.

Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

PLoS One, 2013; 8(2): e55525. 10.1371/journal.pone.0055525
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH.

Antibody maturation and viral diversification in HIV-infected women.

PLoS One, 2013; 8(2): e57350. 10.1371/journal.pone.0057350
Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O.

Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

AIDS Res Hum Retroviruses, 2013; 29(8): 1146-50. 10.1089/AID.2012.0105
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Celentano DD, Morin SF, Sweat M, Coates T, Eshleman SH.

Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).

PLoS One, 2013; 8(7): e68349. 10.1371/journal.pone.0068349
Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH.

Cross-sectional HIV incidence estimation in HIV prevention research.

J Acquir Immune Defic Syndr, 2013; 63 Supplement 2: S233-9. 10.1097/QAI.0b013e3182986fdf
Curtis KA, Longosz AF, Kennedy MS, Keating S, Heitman J, Laeyendecker O, Owen SM.

Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection.

PLoS One, 2013; 8(10): 77765. 10.1371/journal.pone.0077765
Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Karim QA, Naranbhai V, Lingappa JR, Sweat MD, Coates T, Eshleman SH.

Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.

PLoS One, 2013; 8(11): e78818. 10.1371/journal.pone.0078818
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O.

Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.

PLoS One, 2013; 8(12): e82772. 10.1371/journal.pone.0082772
Ng KY, Chew KK, Kaur P, Kwan JY, Khong WX, Lin L, Chua A, Tan MT, Quinn TC, Laeyendecker O, Leo YS, Ng OT.

High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.

BMC Infect Dis, 2013; 13: 90. 10.1186/1471-2334-13-90
Ng KT, Ng KY, Khong WX, Chew KK, Singh PK, Yap JK, Tan MT, Leo YS, Laeyendecker O, Quinn TC, Kamarulzaman A, Tee KK, Ng OT.

Phylodynamic profile of HIV-1 subtype B, CRF01_AE and the recently emerging CRF51_01B among men who have sex with men (MSM) in Singapore.

PLoS One, 2013; 8(12): e80884. 10.1371/journal.pone.0080884
Pena-Cruz V, Etemad B, Chatziandreou N, Nyein PH, Stock S, Reynolds SJ, Laeyendecker O, Gray RH, Serwadda D, Lee SJ, Quinn TC, Sagar M.

HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners.

Retrovirology, 2013; 10: 162. 10.1186/1742-4690-10-162
Shirreff G, Alizon S, Cori A, Günthard HF, Laeyendecker O, van Sighem A, Bezemer D, Fraser C.

How effectively can HIV phylogenies be used to measure heritability?

Evol Med Public Health, 2013; 1: 209-224. 10.1093/emph/eot019
Shardell M, Reich NG, Perencevich EN.

Commentary: Back to the future with Sir Bradford Hill: statistical analysis with hospital-acquired infections.

Int J Epidemiol, 2013; 42(5): 1509-1510. 10.1093/ije/dyt166
Lessler J, Metcalf CJ.

Balancing evidence and uncertainty when considering rubella vaccine introduction.

PLoS One, 2013; 8: e67639. 10.1371/journal.pone.0067639
Cutts FT, Lessler J, Metcalf CJ.

Measles elimination: progress, challenges and implications for rubella control.

Expert Rev Vaccines, 2013; 12: 917-32. 10.1586/14760584.2013.814847
Tobian AA, Grabowski MK, Serwadda D, Newell K, Ssebbowa P, Franco V, Nalugoda F, Wawer MJ, Gray RH, Quinn TC, Reynolds SJ; Rakai Health Sciences Program.

Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.

J Infect Dis, 2013; 208: 839-46. 10.1093/infdis/jit252
Tobian AA, Grabowski MK, Kigozi G, Gravitt PE, Eaton KP, Serwadda D, Nalugoda F, Wawer MJ, Quinn TC, Gray RH.

High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda.

Sex Transm Infect, 2013; 89: 122-7. 10.1136/sextrans-2012-050524
Redd AD, Wendel SK, Grabowski MK, Ocama P, Kiggundu V, Bbosa F, Boaz I, Balagopal A, Reynolds SJ, Gray RH, Serwadda D, Kirk GD, Quinn TC, Stabinski L.

Liver stiffness is associated with monocyte activation in HIV-infected Ugandans without viral hepatitis.

AIDS Res Hum Retroviruses, 2013; 29: 1026-30. 10.1089/AID.2013.0004